
Semax is a synthetic peptide based on the ACTH(4-10) fragment, studied as a nootropic and neuroprotective research compound. Supplied for laboratory research use only.
Semax is a synthetic heptapeptide derived from the 4–10 fragment of adrenocorticotropic hormone (ACTH), modified for metabolic stability. Developed in Russia, it is studied for nootropic, neuroprotective and neurorestorative activity without the hormonal action of full-length ACTH.
Research reports rapid increases in brain-derived neurotrophic factor (BDNF) and its trkB receptor signalling, modulation of the melanocortin system, and effects on dopaminergic and serotonergic transmission in cell and animal models.
| Area | Reported research focus |
|---|---|
| Focus & cognition | Attention and learning pathways in research models. |
| Neuroprotection | Ischaemic and hypoxic injury models. |
| Neuroplasticity | BDNF and NGF expression. |
| Specification | Detail |
|---|---|
| Product | Semax |
| Format | Lyophilised vial or nasal spray |
| Fill | 5 mg |
| Molecular formula | C37H51N9O10S |
| Purity | Specified to a 99%+ purity target — per-batch documentation will be published once independent lab testing completes |
| Price | €30.00 (vial) · €35.00 (nasal spray) |
| Availability | In stock — dispatched from Ireland within 1–2 working days, tracked |
| Supplied for | Laboratory research use only — not for human consumption, diagnostic or therapeutic use |
Every production batch is sent for independent, third-party analysis at Janoshik Analytical. When results return, the full Certificate of Analysis for the exact batch you receive is published here and in our COA library, carrying its SHA-256 checksum and the lot number printed on your vial, so you can confirm the document is genuine and untampered. We publish every certificate, including any that fail.
Occasional, useful email: new-batch and restock notices, the free reconstitution calculator and guides, plus FIRST10 for 10% off your first order. No daily blasts.